Kindly Md, Inc. SEC Filings

Perianne Boring McNulty, a director of Kindly MD, Inc. (NAKA), reported acquiring 112,781 restricted stock units on 09/22/2025. The RSUs were granted at a $0 price and are scheduled to vest on August 15, 2026, subject to her continued service on the company's board through the vesting date. After this transaction the reporting person beneficially owns 112,781 shares in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 09/24/2025.

Kindly MD, Inc. (NAKA) director Charles Phillip Blackburn was granted 112,781 restricted stock units (RSUs) on 09/22/2025, recorded on a Form 4 filed 09/24/2025. The RSUs carry a $0 purchase price and are reported as directly beneficially owned following the grant.

The RSUs are subject to time-based vesting and will vest on August 15, 2026 provided Blackburn continues to serve on the company’s board through that Vesting Date. After the reported transaction, Blackburn is shown as beneficial owner of 112,781 shares tied to these RSUs.

Kindly MD, Inc. discloses material risks and shareholder details in this S-3ASR filing. The company warns that costs and potential litigation related to a proposed Merger have been and will be incurred, that trading of its securities may be volatile, and that shareholders may face dilution from warrant exercises and future equity issuances. The filing highlights industry-specific regulatory risk for medical cannabis, competitive and technology threats, reliance on key management, and cybersecurity concerns. Significant beneficial ownership stakes are shown, including a holder with 133,928,571 shares (27.19%) and another with 114,246,002 shares (23.94%), and a large block totaling 53,571,429 shares (13.57%). The registrant describes permitted distribution methods for registered shares and undertakes post-effective filing obligations. The document includes officer and director signatures certifying the filing.

Kindly MD, Inc. filed an 8-K reporting current beneficial ownership information for its common stock and tradeable warrants. The filing lists individual holdings for directors and executive officers and aggregates that all officers and directors as a group hold 21,798,017 shares, representing 5.80% of the outstanding common stock. It also discloses a significant institutional holder, Verition Multi-Strategy Master Fund Ltd., owning 37,781,847 shares, equal to 9.99% of the company. The filing is a routine ownership disclosure showing insider positions and a near-10% outside stake, without other transaction, financial performance, or management-change detail.

Kindly MD, Inc. (NAKA) filed an S-3ASR describing securities offerings, post‑merger capital changes and risk factors. The filing discloses the company may use proceeds for a Bitcoin Treasury Strategy, working capital, debt repayment, acquisitions, capital expenditures, projects or share repurchases. It lists detailed terms that may govern future debt securities, warrants, rights and units. The company warns of costs and potential litigation from the Merger, post‑closing volatility in its stock, future dilution from outstanding warrants, a convertible debenture and PIPE issuances, operational and regulatory risks (including implementing a bitcoin treasury operation and crypto regulation risks), and cyber and IP risks. The Registrant states its common stock trades on Nasdaq under NAKA and references recent SEC filings and exhibits that update its capital stock description.

Kindly MD, Inc. filed an amended Current Report (Form 8-K/A) that attaches exhibit-level disclosures for Nakamoto Holdings, Inc. The filing identifies the company's trading symbols as NAKA on The Nasdaq Stock Market LLC and NAKAW on the OTC Pink Market. It includes the consent of Wolf & Company, P.C., audited financial statements of Nakamoto as of April 30, 2025 and for the period from March 6, 2025 (inception) to April 30, 2025, unaudited financials as of June 30, 2025, unaudited pro forma condensed combined financial statements reflecting the acquisition of Nakamoto, supplemental risk factors, and management discussion and analysis for the stated periods. The filing is executed by CEO David Bailey.

Tyler Matthew Evans, identified as Chief Investment Officer and a director of Kindly MD, Inc. (NAKA), reported on Form 4 that on 08/14/2025 he acquired 2,232,114 shares of the issuer’s common stock at a reported price of $0, increasing his total beneficial ownership to 2,410,685 shares. The filing is signed on 08/22/2025. The form shows a non-derivative acquisition only and provides no additional explanatory detail about the mechanics or consideration for the transaction.